Cambridge Investment Research Advisors Inc. lowered its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 161,874 shares of the company’s stock after selling 3,784 shares during the period. Cambridge Investment […]